Mounjaro vs. Zepbound

Q: Is Zepbound the same as Mounjaro?

Yes — both Zepbound and Mounjaro contain tirzepatide, the same active ingredient. The difference is in their FDA approvals: Mounjaro is approved for type 2 diabetes, while Zepbound is approved for chronic weight management in adults with obesity.

Q: Which has a higher dose — Mounjaro or Zepbound?

Both reach the same maximum dose of 15mg per week. The dose escalation schedule is identical: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg.

Q: Can I use Mounjaro for weight loss?

Mounjaro can be prescribed off-label for weight loss, but insurance typically won't cover it for this purpose without a diabetes diagnosis. Zepbound is the on-label option for weight management and is more likely to be covered by weight-loss benefit plans.

Same Tirzepatide. Two Brand Names. Here's Why It Matters.

Mounjaro and Zepbound both contain tirzepatide — Eli Lilly's dual GLP-1/GIP receptor agonist. The brand name is different because the FDA approval is different. Here's what that means for you.

⚖️ Side-by-Side💉 Same Molecule🏥 Insurance Matters

Download on theApp Store

Become aBeta Tester

Feature	Mounjaro	Zepbound
Active Ingredient	Tirzepatide	Tirzepatide
FDA Approval	Type 2 Diabetes	Chronic Weight Management + Sleep Apnea
Max Weekly Dose	15mg	15mg
Average Weight Loss	~21% body weight	~20% body weight
Sleep Apnea Approval	No	Yes (2024)
Insurance (Diabetes)	Usually covered	Usually not
Insurance (Weight)	Off-label only	Covered if qualifying
Pen Format	Single-use auto-injector	Single-use auto-injector

Why Two Brand Names Exist

Pharmaceutical companies routinely seek separate FDA approvals for different indications — even when the drug is identical. This allows them to market the product to different specialties (endocrinology vs obesity medicine), set different pricing tiers, and negotiate insurance coverage separately.

Zepbound was approved in November 2023 for weight management, and in 2024 it became the first medication ever approved specifically for obstructive sleep apnea. This makes Zepbound the more versatile option if you have multiple weight-related conditions.

If you have type 2 diabetes, your doctor will likely prescribe Mounjaro (better insurance coverage). If your primary goal is weight loss or you have sleep apnea, Zepbound is the on-label choice.

Common Questions

Is Zepbound the same as Mounjaro?

Yes — both contain tirzepatide at identical doses. The distinction is purely in FDA indication and brand positioning. If you switched from Mounjaro to Zepbound, you're taking the exact same drug.

Which has a higher dose — Mounjaro or Zepbound?

Both reach the same maximum of 15mg per week, with the same dose escalation schedule. There is no pharmacological difference between the two products.

Can I use Mounjaro for weight loss?

Yes, doctors can prescribe Mounjaro off-label for weight loss, but your insurance likely won't cover it without a diabetes diagnosis. Zepbound is the FDA-approved on-label option for weight management.

How do I track Mounjaro or Zepbound doses?

Shotlee supports both Mounjaro and Zepbound with full dose escalation tracking (2.5mg through 15mg), injection site rotation, side effect logging, and weekly reminders.

Track Mounjaro or Zepbound — Free

Whether your prescription says Mounjaro or Zepbound, Shotlee tracks every tirzepatide dose from 2.5mg to 15mg with weekly reminders and progress charts.

🚀 Get Shotlee Free